Mar 12, 2019 / 02:30PM GMT
Operator
Thank you for standing by, and welcome to the Smith & Nephew Acquires Osiris Therapeutics Conference Call. (Operator Instructions) I must advise you that the conference is being recorded today, Tuesday the 12th of March 2019. I will now read the forward-looking statements. Certain statements in this presentation are forward-looking statements. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from those included in these statements due to a variety of factors. More information about these factors is contained in the company's filings to the Securities and Exchange Commission. I would now like to hand the conference over to your speaker today, CEO, Namal Nawana. Please go ahead, sir.
Namal Nawana - Smith & Nephew plc - CEO & Executive Director
Good morning, or good afternoon, to those of you in Europe. Welcome to our conference call on our agreement to acquire Osiris Therapeutics. With me on the call are Graham Baker, Chief Financial Officer;
Smith & Nephew PLC to Acquire Osiris Therapeutics Inc Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot